Fresh out of the oven! Great read: HIPEC for Colorectal peritoneal Mets Annals of Surgical Oncology link.springer.com/article/10.124… UChicago Surgery UChicago Medicine UChicago Pritzker School of Medicine Jason M Foster Garrett Nash

#ClinicalTrial EA2222/PUMP, led by Michael Lidsky, MD, FACS, is a randomized phase 3 study of #SystemicTherapy with or without hepatic arterial infusion for unresectable #Colorectal liver metastases. More here: bit.ly/ea2222-pump cc: Michael D’Angelica, Shishir K. Maithel, Andrea Cercek

Prof Buchler ChampalimaudF gives his “Lessons For Young Surgeons” and his “Lessons For The Teachers” at the EPC-Europ Pancr Club #EPC2025. A living legend 👑 in #Pancreas #Surgery

Organ preservation is definitely not controversial with this group of KOLs. Fantastic to have trailblazing surgeons like them pushing the 💉 (literally). Julio Garcia Aguilar Laura Fernandez Geerard Beets #ESMOGI25 #ESMOAmbassadors ESMO - Eur. Oncology

Interesting and promising data re: #vaccine therapy in #pancreatic #cancer from Vinod BalachandranMD ESMO - Eur. Oncology Memorial Sloan Kettering Cancer Center Eileen M O’Reilly PanCAN #ESMOGI2025 #ESMOAmbassadors

Great article Chris Cann, MD and Dr. Cathy Eng

In #ClinicalTrial EA2222/PUMP, investigators are testing #PumpChemo in addition to SOC chemo versus SOC chemo alone for patients with unresectable #ColorectalCancer liver metastases. For more: bit.ly/ea2222-pump cc : Michael Lidsky, MD, FACS

The IGNYTE Trial, presented by Dr. Georgia Beasley at #SSO2025, is now online Journal of Clinical Oncology! Read about RP1 combined with Nivo for Patients with Advanced PD-1-Failed Melanoma ⬇️ ascopubs.org/doi/10.1200/JC… Duke Surgery Duke Cancer

This is a great meeting for anyone who treats patients with regional therapies for peritoneal disease, melanoma, and advanced hepatic malignancies. Society of Surgical Oncology

Important work in re-evaluating how we consider and treat Stage IV #breastcancer from a great team led by Jennifer Plichta MD (she/her)

🚨 Wonderful new work from Team Plichta (Jennifer Plichta MD (she/her)) and the awesome Duke Breast Surg Onc crew in ACS Journal Cancer: LauraRosenbergerMD Gayle DiLalla Shelley Hwang Ton Wang Kendra Parrish Hannah Woriax

Congrats Victoria Haney , welcome to Duke Surgery and Duke Surgical Oncology

Be sure to register for the upcoming SUS Office hours: bit.ly/SUSOfficeHours…

.Michael Lidsky, MD, FACS of Duke Surgical Oncology and Duke Cancer is leading EA2222/PUMP, a randomized phase 3 study for patients with #Colorectal liver metastases. Learn more: bit.ly/ea2222-pump cc : Colorectal Cancer Alliance, @LiverUSA

🌟 We're excited to share we have matched for our 2026-2028 Abdominal Transplant Fellowship with Drs. Daniel Firl and Gan Zhen! We look forward to welcoming you to Stanford next year! 🌲 Daniel Firl Duke Surgery

#FacultyResearch: A new The Lancet paper co-authored by Lisa McElroy, MD, Assistant Professor of Surgery, and a multinational team of researchers and surgeons, examines how policy can be a tool to advance transplantation equity. Read more: bit.ly/44P41xK Duke University School of Medicine

Congratulations to DCI's Nicole Larrier, MD, on being named a 2025 ASTRO fellow! This designation has been awarded to 541 of ASTRO’s 10,000 members worldwide since its inception in 2006. duke.is/c/euhp Duke University School of Medicine | Duke Radiation Oncology

#ClinicalTrial EA2222/PUMP, led by Michael Lidsky, MD, FACS, is a randomized phase 3 study of #SystemicTherapy with or without hepatic arterial infusion for unresectable #Colorectal liver metastases. More here: bit.ly/ea2222-pump cc: Michael D’Angelica, Shishir K. Maithel, Andrea Cercek

Congratulations to DCI's Kris Wood, PhD, on receiving this year's All-Star Translational Cancer Research Grant from The V Foundation for Cancer Research. Wood's research will focus on drugs that can kill residual #LungCancer cells. duke.is/2/mfxt Duke Health | Duke Pharmacology & Cancer Biology Department

.Michael Lidsky, MD, FACS of Duke Surgical Oncology and Duke Cancer is leading EA2222/PUMP, a randomized phase 3 study for patients with #Colorectal liver metastases. Learn more: bit.ly/ea2222-pump cc : Colorectal Cancer Alliance, @LiverUSA